Agile Therapeutics, Inc. Profile Avatar - Palmy Investing

Agile Therapeutics, Inc.

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combinatio…

Drug Manufacturers - Specialty & Generic
US, Princeton [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Agile Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Agile Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Agile Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of AGRX's Analysis
CIK: 1261249 CUSIP: 00847L100 ISIN: US00847L3087 LEI: - UEI: -
Secondary Listings
AGRX has no secondary listings inside our databases.